ESC 2023 | ECLS-Shock

Cardiogenic shock (CS) represents the main cause of death in patients hospitalized for acute myocardial infarction (AMI). Despite advances in its management, mortality continues to be high, between 40-50% within the first 30 days. In an attempt to improve survival, early extracorporeal life support (ECLS) is being increasingly used to stabilized hemodynamics in cases of serious shock, especially the use of venoarterial extracorporeal membrane oxygenation (VA-ECMO), also called ECLS. 

ESC 2023

Evidence on the efficacy of VA-ECMO in the context of AMI and CS is based mainly on observational studies or small randomized trials. The ECLS-SHOCK is the first randomized clinical trial on VA-ECMO to look into mortality in patients with CS undergoing early revascularization. The study included patients from centers in Germany and Slovenia, mean age 63, and 19% were women.

Primary end point was all-cause mortality at 30 days. Secondary end points included length of mechanical ventilation, time to hemodynamic stabilization and need for renal replacement therapy. As regards safety, researchers looked into bleeding events (from moderate to severe) and peripheral vascular complications requiring intervention. 

Read also: ESC 2023 | STOPDAPT-3.

The final analysis considered a total of 417 patients. Primary end point occurred in 47.8% patients in the VA-ECMO group and 49% in the control group ([RR] 0.98, CI 95%, 0.80-1.19; p=0.81). Length of mechanical ventilation was higher in the VA-ECMO group (7 vs 5 days). Also, time to hemodynamic stabilization and need for renal replacement therapy rate were similar.  

As regards safety end points, there were more bleeding events in the VA-ECMO group (RR 2.44, CI 95% 1.50-3.95) and more interventions for peripheral vascular complications (RR 2.86, CI 95% 1.31-6.25).

Dr. Omar Tupayachi

Dr. Omar Tupayachi.
Member of the Editorial Board of SOLACI.org.

Source: Presented at the Hot Line Sessions, Agosto 26, ESC Congreess 2023, Amsterdam.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Sheathless Femoral Impella: A New Strategy to Reduce Vascular Complications in High-Risk PCI?

Patients with complex coronary artery disease or cardiogenic shock undergoing percutaneous coronary intervention (PCI) may benefit from the hemodynamic support provided by percutaneous ventricular...

OCT- and IVUS-Guided Coronary Angioplasty in Acute Coronary Syndrome: Long-Term Clinical Outcomes

Percutaneous coronary angioplasty (PCI) in patients with acute coronary syndrome (ACS) has reduced mortality in the acute phase. However, recurrent ACS and target vessel...

Rolling Stone: Registry of Intravascular Lithotripsy vs Atherectomy Use in Complex Calcified Lesions

Severe coronary calcification represents one of the main challenges in performing percutaneous coronary intervention, both due to the higher risk of stent underexpansion and...

Morpheus Global Registry: Safety and efficacy of the long tapered BioMime™ Morph stent in complex coronary lesions

Percutaneous coronary intervention in long coronary lesions continues to represent a technical and clinical challenge, in which the use of conventional cylindrical stents may...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Low-Dose Rivaroxaban After Peripheral Angioplasty: Effectiveness and Safety in Real-World Clinical Practice

Following lower limb revascularization, optimal medical therapy includes antiplatelet agents, high-intensity statins, and control of cardiovascular risk factors. Recent studies such as COMPASS and...

Sheathless Femoral Impella: A New Strategy to Reduce Vascular Complications in High-Risk PCI?

Patients with complex coronary artery disease or cardiogenic shock undergoing percutaneous coronary intervention (PCI) may benefit from the hemodynamic support provided by percutaneous ventricular...

OCT- and IVUS-Guided Coronary Angioplasty in Acute Coronary Syndrome: Long-Term Clinical Outcomes

Percutaneous coronary angioplasty (PCI) in patients with acute coronary syndrome (ACS) has reduced mortality in the acute phase. However, recurrent ACS and target vessel...